Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 5/20 | 0.67 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.66 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.62 |
| ▸ | CASP2 | P42575 | 1/20 | 0.62 |
| ▸ | NAAA | Q02083 | 1/20 | 0.58 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.55 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.54 |
| ▸ | SELP | P16109 | 1/20 | 0.54 |
| ▸ | CNR1 | P21554 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16852243 | 1.00 | FAAH (0.67) | FAAHSLC6A5DNM1CASP2NAAA | |
| SCHEMBL10031646 | 1.00 | FAAH (0.67) | FAAHSLC6A5DNM1CASP2NAAA | |
| SCHEMBL1984951 | 1.00 | FAAH (0.67) | FAAHSLC6A5DNM1CASP2NAAA | |
| SCHEMBL1813350 | 1.00 | FAAH (0.67) | FAAHSLC6A5DNM1CASP2NAAA | |
| SCHEMBL3914543 | 1.00 | FAAH (0.67) | FAAHSLC6A5DNM1CASP2NAAA | |
| SCHEMBL23673836 | 1.00 | FAAH (0.67) | FAAHSLC6A5DNM1CASP2NAAA | |
| SCHEMBL3910766 | 1.00 | FAAH (0.67) | FAAHSLC6A5DNM1CASP2NAAA | |
| SCHEMBL7777076 | 1.00 | FAAH (0.67) | FAAHSLC6A5DNM1CASP2NAAA | |
| SCHEMBL6894367 | 1.00 | FAAH (0.67) | FAAHSLC6A5DNM1CASP2NAAA | |
| SCHEMBL1813706 | 1.00 | FAAH (0.67) | FAAHSLC6A5DNM1CASP2NAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121851023-A | Cell membrane marked molecular probe, preparation method and application thereof in imaging direction of drug-resistant bacteria | 广州大学 | 2026-04-14 | — | — | CN | disclosed |
| US-9844621-B2 | Separation material | GAMBRO LUNDIA AB (SE) | 2017-12-19 | — | — | US | disclosed |
| US-9259710-B2 | Separation material comprising saccharide ligands | Gambro Lunia AB (SE) | 2016-02-16 | — | — | US | disclosed |
| US-20150111194-A1 | SEPARATION MATERIAL COMPRISING SACCHARIDE LIGANDS | GAMBRO LUNDIA AB (SE) | 2015-04-23 | — | — | US | disclosed |
| CN-104053462-A | SEPARATION MATERIAL COMPRISING SACCHARIDE LIGANDS | GAMBRO LUNDIA AB | 2014-09-17 | — | — | CN | disclosed |
| US-20140166580-A1 | SEPARATION MATERIAL | GAMBRO LUNDIA AB (SE) | 2014-06-19 | — | — | US | disclosed |
| EP-2741796-A1 | SEPARATION MATERIAL | Gambro Lundia AB (SE) | 2014-06-18 | — | — | EP | disclosed |
| EP-2741795-A1 | SEPARATION MATERIAL COMPRISING SACCHARIDE LIGANDS | Gambro Lundia AB (SE) | 2014-06-18 | — | — | EP | disclosed |
| WO-2013020967-A1 | SEPARATION MATERIAL | GAMBRO LUNDIA AB (SE) | 2013-02-14 | — | — | WO | disclosed |
| WO-2013020964-A1 | SEPARATION MATERIAL COMPRISING SACCHARIDE LIGANDS | GAMBRO LUNDIA AB (SE) | 2013-02-14 | — | — | WO | disclosed |
| EP-2556848-A1 | Separation material comprising saccharide ligands | Gambro Lundia AB (SE) | 2013-02-13 | — | — | EP | disclosed |
| EP-2556849-A1 | Separation material | Gambro Lundia AB (SE) | 2013-02-13 | — | — | EP | disclosed |